NASDAQ:ARGX - argenx SE
$124.74
 $7.90
+6.76%
1:45PM EDT
2019-02-15
argenx SE, formerly arGEN X BV is the Netherlands-based biopharmaceutical company. It creates and develops a pipeline of differentiated antibody therapeutics using its discovery platform, Simple Antibody, which exploits characteristics of the llama immune system. The Company develops a pipeline of antibody therapeutics focused on cancer and autoimmune indications. It includes: ARGX-110, an antibody for heme malignancies and solid tumors, which modulates functions of tumor such as cell proliferation and survival; ARGX-111, an antagonist of c-Met, a receptor tyrosine kinase involved in cell proliferation, angiogenesis and metastasis in multiple solid tumors; ARGX-112, an antigen which targets atopic dermatitis by neutralization of IL-20 and IL-22 (interleukin) mediated signaling through blockade of their common receptor, among others. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  ARGX     avg for
industry  
  avg for
sector  
42 stocks weight:  75. 63   0. 00   0. 00  
42 stocks rank:  2. 20 K 1. 86 K 1. 09 K
# analyst opinions:  9. 00   14. 92   14. 43  
mean recommendation:  1. 70   1. 91   1. 93  


target price low:  129. 46   88. 97   117. 82  
target price avg:  146. 15   115. 19   141. 96  
target price high:  159. 11   143. 40   163. 16  
1-yr high:  116. 84   124. 30   142. 77  
last close:  116. 84   101. 85   127. 84  
50-day avg:  104. 25   98. 27   122. 46  
200-day avg:  92. 40   99. 72   122. 70  
1-yr low:  63. 81   78. 19   100. 16  
volume:  136. 69 K 2. 38 M 4. 64 M
50-day avg volume:  209. 79 K 3. 31 M 4. 94 M
200-day avg volume:  193. 16 K 3. 23 M 4. 28 M

1-day return:  2. 53 % 0. 22 % 0. 48 %
this week return:  7. 24 % 1. 77 % 2. 01 %
12-wk return:  28. 07 % 6. 56 % 3. 33 %
52-wk return:  37. 09 % -2. 23 % 14. 35 %

enterprise value (EV):  3. 54 B 55. 17 B 104. 51 B
market cap:  4. 36 B 49. 01 B 96. 46 B

shares outstanding:  32. 45 M 607. 99 M 1. 22 B
shares:  30. 59 M 605. 53 M 1. 15 B
shares short:  945. 97 K 11. 62 M 12. 55 M
shares short prior month:  621. 14 K 11. 95 M 13. 44 M
short ratio:  4. 00   4. 82   3. 10  

book value:  11. 95   14. 43   28. 26  
price/book:  9. 77   -1. 57   -2. 97  
gross profits:  -10. 48 M 8. 28 B 18. 09 B
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  -159. 45 % 13. 81 % 22. 47 %
profit margins:  -136. 25 % 6. 57 % 9. 92 %
gross margins:  -94. 64 % 49. 33 % 54. 53 %

1-yr max volatility:  20. 05 % --- ---
1-yr mean volatility:  0. 19 % 0. 01 % 0. 06 %

1-yr EPS:  -1. 73   3. 03   4. 09  
forward EPS:  -1. 43   4. 33   6. 99  
P/E:  -67. 73   6. 11   26. 91  
forward P/E:  -76. 19   8. 38   10. 48  
PE/G:  1. 72   0. 37   5. 61  
growth:  -39. 30 % 683. 72 % 104. 79 %
earnings high:  -0. 62   1. 27   1. 66  
earnings avg:  -0. 72   1. 01   1. 53  
earnings low:  -0. 90   0. 76   1. 40  
revenue high:  11. 34 M 2. 86 B 11. 19 B
revenue avg:  8. 45 M 2. 78 B 10. 84 B
revenue low:  5. 27 M 2. 67 B 10. 64 B
revenue growth:  -39. 30 % 648. 36 % 97. 70 %

beta (1yr vs S&P500):  0. 82   1. 21   0. 93  
sharpe (1yr):  0. 98   0. 06   0. 98  

held % insiders:  0. 00 % 6. 46 % 3. 21 %
held % institutions:  56. 07 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : ARGX
.    + 9.084 =         9.084 :: INITIAL WEIGHT
.   + 63.869 =        72.953 :: inverse volume-to-price addition
.  + 339.992 =       412.946 :: spline projection addition
.  + 700.934 =      1113.879 :: notable performance addition
.  - 100.563 =      1013.317 :: poor performance penalty
.    x 1.434 =      1452.711 :: one-year gains+dividend factor
.     x 9.81 =     14251.305 :: 13 weeks' performance factor
.    x 1.492 =     21269.914 :: industry recommendation factor
.    x 2.731 =     58085.317 :: symbol recommendation factor
.    x 0.996 =     57857.042 :: revenue growth factor
.    x 1.118 =     64686.139 :: short ratio factor
.    x 2.203 =    142477.768 :: price-to-book factor
.    x 1.216 =    173252.077 :: 5-day avg > 200-day avg
.    x 1.078 =    186729.809 :: 5-day avg > 50-day avg
.    x 1.128 =    210673.445 :: 50-day avg > 200-day avg
.    x 1.021 =    215052.085 :: P/E weight
.    x 0.873 =    187690.021 :: PE/G factor
.    x 1.713 =    321527.261 :: beta factor
.    x 0.983 =    316066.492 :: sharpe factor
.    x 1.333 =    421187.576 :: target low factor
.    x 1.167 =    491505.563 :: target mean factor
.     x 1.06 =    521068.582 :: target high factor
.    x 1.066 =    555257.354 :: industry 12-weeks return
.    x 0.981 =      544978.5 :: "drift" penalty 3 days ago
.    x 0.993 =    541266.422 :: "drift" penalty 5 days ago
.      x 1.0 =    541099.796 :: overall "drift" factor
.      x 0.8 =    432622.843 :: largest single-day jump factor
.      x 1.0 =    432651.882 :: factor hist industry gain for week 06
.   cubeRoot =        75.633 :: reduced for readability
.                     75.633 :: FINAL WEIGHT for NASDAQ:ARGX


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org